Skip to Main Content

Author Details

Hannah Carter
University of California San Diego
2008
99
39
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36305680Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program.J Natl Cancer Inst2023
36250634The Cancer Epitope Database and Analysis Resource (CEDAR).Nucleic Acids Res2023
36305680Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program.J Natl Cancer Inst2023
37945900Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma.Nat Genet2023
37577681Interface-guided phenotyping of coding variants in the transcription factor RUNX1 with SEUSS.bioRxiv2023
37637234Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant Relapse.J Immunother Precis Oncol2023
36909826Transcriptional analysis links B cells and TERT expression to favorable prognosis in head and neck cancer.PNAS Nexus2023
370855393D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.Nat Commun2023
37461500Epigenetic Germline Variants Predict Cancer Prognosis and Risk and Distribute Uniquely in Topologically Associating Domains.bioRxiv2023
36629482Response to Haiman, Kote-Jarai, Darst et al.J Natl Cancer Inst2023
37308665The GPCR-Gα<sub>s</sub>-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure.Nat Immunol2023
37173324Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response.Nat Commun2023
37945900Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma.Nat Genet2023
37577681Interface-guided phenotyping of coding variants in the transcription factor RUNX1 with SEUSS.bioRxiv2023
37637234Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant Relapse.J Immunother Precis Oncol2023
37461500Epigenetic Germline Variants Predict Cancer Prognosis and Risk and Distribute Uniquely in Topologically Associating Domains.bioRxiv2023
370855393D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.Nat Commun2023
37308665The GPCR-Gα<sub>s</sub>-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure.Nat Immunol2023
37173324Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response.Nat Commun2023
36909826Transcriptional analysis links B cells and TERT expression to favorable prognosis in head and neck cancer.PNAS Nexus2023
36629482Response to Haiman, Kote-Jarai, Darst et al.J Natl Cancer Inst2023
36250634The Cancer Epitope Database and Analysis Resource (CEDAR).Nucleic Acids Res2023
34432150Predicting functional consequences of mutations using molecular interaction network features.Hum Genet2022
36314681Subcellular location of source proteins improves prediction of neoantigens for immunotherapy.EMBO J2022
35647109Assessment of Diversity of Antimicrobial Resistance Phenotypes and Genotypes of <i>Mannheimia haemolytica</i> Isolates From Bovine Nasopharyngeal Swabs.Front Vet Sci2022
36151408Publisher Correction: Predicting functional consequences of mutations using molecular interaction network features.Hum Genet2022
36575447Accurate genome-wide genotyping from archival tissue to explore the contribution of common genetic variants to pre-cancer outcomes.J Transl Med2022
36494783PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry.BMC Cancer2022
34432150Predicting functional consequences of mutations using molecular interaction network features.Hum Genet2022
35647109Assessment of Diversity of Antimicrobial Resistance Phenotypes and Genotypes of <i>Mannheimia haemolytica</i> Isolates From Bovine Nasopharyngeal Swabs.Front Vet Sci2022
36575447Accurate genome-wide genotyping from archival tissue to explore the contribution of common genetic variants to pre-cancer outcomes.J Transl Med2022
36494783PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry.BMC Cancer2022
36314681Subcellular location of source proteins improves prediction of neoantigens for immunotherapy.EMBO J2022
36151408Publisher Correction: Predicting functional consequences of mutations using molecular interaction network features.Hum Genet2022
33974857Intratumoral bacteria generate a new class of therapeutically relevant tumor antigens in melanoma.Cancer Cell2021
33914028Increasing metadata coverage of SRA BioSample entries using deep learning-based named entity recognition.Database (Oxford)2021
33952700Immune evasion in HPV<sup>-</sup> head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p loss.Proc Natl Acad Sci U S A2021
33571241In silico analysis suggests less effective MHC-II presentation of SARS-CoV-2 RBM peptides: Implication for neutralizing antibody responses.PLoS One2021
34095869A phenotypically supervised single-cell analysis protocol to study within-cell-type heterogeneity of cultured mammalian cells.STAR Protoc2021
33558336Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response.Cancer Res2021
33602823Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation.Proc Natl Acad Sci U S A2021
33974857Intratumoral bacteria generate a new class of therapeutically relevant tumor antigens in melanoma.Cancer Cell2021
34465181Neoantigen Controversies.Annu Rev Biomed Data Sci2021
34504503The Cancer Epitope Database and Analysis Resource: A Blueprint for the Establishment of a New Bioinformatics Resource for Use by the Cancer Immunology Community.Front Immunol2021
34503567Non-cancer-related pathogenic germline variants and expression consequences in ten-thousand cancer genomes.Genome Med2021
34493867Genomic and evolutionary classification of lung cancer in never smokers.Nat Genet2021
33602823Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation.Proc Natl Acad Sci U S A2021
33571241In silico analysis suggests less effective MHC-II presentation of SARS-CoV-2 RBM peptides: Implication for neutralizing antibody responses.PLoS One2021
33558336Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response.Cancer Res2021
33914028Increasing metadata coverage of SRA BioSample entries using deep learning-based named entity recognition.Database (Oxford)2021
  • 1 - 50 of 198

Recommended Authors

McDonnell Genome Institute, Siteman Cancer Center, Washington University in St. Louis
Career Start Year 2016
Number of shared co-authors 6
St. Jude Children's Research Hospital
Career Start Year 2014
Number of shared co-authors 5
Department of Biology at Brigham Young University
Career Start Year 2013
Number of shared co-authors 12
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 7
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 3
Washington University
Career Start Year 2009
Number of shared co-authors 12
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 4
University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 24
German Cancer Research Centre DKFZ
Career Start Year 2007
Number of shared co-authors 9
University of Oslo
Career Start Year 2007
Number of shared co-authors 5
Center for Molecular Medicine, University Medical Center Utrecht
Career Start Year 2006
Number of shared co-authors 3
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 23
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 18
The Broad Institute of Harvard and MIT
Career Start Year 2005
Number of shared co-authors 22
University of Augsburg
Career Start Year 2004
Number of shared co-authors 21
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 23
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 25
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 16
Washington University
Career Start Year 2003
Number of shared co-authors 19
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 20
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year 2003
Number of shared co-authors 15
Washington University
Career Start Year 2003
Number of shared co-authors 17
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 9
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 6
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 56
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 5
The Broad Institute of Harvard and MIT
Career Start Year 1998
Number of shared co-authors 28
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 4
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 28
The Ohio State University
Career Start Year 1988
Number of shared co-authors 35

Collaborators

Johns Hopkins University
Co-authored papers 21
University of California San Diego
Co-authored papers 13
Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University
Co-authored papers 12
University of California San Diego
Co-authored papers 11
David Geffen School of Medicine at university of california los angeles
Co-authored papers 8
University of California San Diego
Co-authored papers 7
Co-authored papers 7
Co-authored papers 7
Fox Chase Cancer Center
Co-authored papers 6
Broad Institute of Harvard and MIT
Co-authored papers 6
University of California
Co-authored papers 6
University of California San Diego
Co-authored papers 5
University of California San Diego
Co-authored papers 5
University of California
Co-authored papers 5
University of California San Diego
Co-authored papers 5
Co-authored papers 5
Moores Cancer Center, university of california san diego
Co-authored papers 5
Co-authored papers 5
Co-authored papers 4
Moores Cancer Center, university of california san diego
Co-authored papers 4
National Human Genome Research Institute, US National Institutes of Health
Co-authored papers 4
Dana Farber Cancer Institute.
Co-authored papers 4
The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH)
Co-authored papers 4
Co-authored papers 4
University of California
Co-authored papers 4
Illumina Inc.
Co-authored papers 4
University of California San Diego
Co-authored papers 3
Washington University in St. Louis.
Co-authored papers 3
Moores Cancer Center, University of California San Diego
Co-authored papers 3
VA San Diego Healthcare System (VASDHS)
Co-authored papers 3